Skip to main content
Improve  Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,954 across all filing types
Latest filing 2020-04-24 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
第四届监事会第十八次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Guangzhou Yangpu Medical Technology Co., Ltd. It mentions the approval of the company's 2020 first quarter report but does not contain the report itself. The document also includes approval for a loan application. The text is short (1011 characters) and refers to the actual quarterly report being available elsewhere (on the designated disclosure website). This fits the pattern of a Regulatory Filing (RNS) as it is an announcement of resolutions and approvals rather than the full financial report or detailed financial data. It is not an Interim/Quarterly Report (IR) because it does not contain substantive financial data itself, only references it. Therefore, the correct classification is Regulatory Filings (RNS).
2020-04-24 Chinese
第四届董事会第二十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from Guangzhou Yangpu Medical Technology Co., Ltd. It reports the approval of the company's 2020 first quarter report by the board of directors and the approval of a loan application. The document references the 2020 first quarter report but does not contain the report itself or detailed financial data. It is a formal announcement of board decisions, including approval of financial reports and financing actions. The document length is short (1031 characters), and it states that the full quarterly report is available elsewhere (on the designated disclosure website). Therefore, this document is best classified as Board/Management Information (MANG) because it announces board meeting resolutions and decisions rather than providing the full interim report or financial statements.
2020-04-24 Chinese
2020年第一季度报告披露提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (390 characters) indicating that the company's 2020 first quarter report has been published and is available on a regulatory website. It does not contain the actual financial data or substantive analysis from the quarterly report itself, but rather directs investors to where the report can be found. This fits the criteria for a Report Publication Announcement (RPA) rather than the Interim/Quarterly Report (IR) itself.
2020-04-24 Chinese
关于公司及子公司获得政府补助的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding government subsidies received by the company and its subsidiaries from January 1, 2020 to April 23, 2020. It details the amounts, types, and accounting treatment of these subsidies, as well as their expected impact on the company's 2020 profits. The document is relatively short (3937 characters) and primarily serves as a disclosure of government grants and their accounting implications. It does not contain comprehensive financial statements or detailed financial performance data typical of an Annual Report or Interim Report. It also does not fit into categories like Earnings Release, Management Reports, or Capital Updates. The document is a regulatory announcement about government subsidies, which is best classified under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit more specific categories.
2020-04-24 Chinese
2017年面向合格投资者公开发行创新创业公司债券(第一期)2020年付息公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the interest payment for a specific bond issued by Guangzhou Yangpu Medical Technology Co., Ltd. It includes bond details such as bond code, interest rate, payment dates, tax information, and payment procedures. The document is titled as a '2020 Interest Payment Announcement' for the 2017 bond issuance. It does not contain financial statements or comprehensive financial performance data, nor is it a report or presentation. It is an update related to the bond's interest payment, which falls under capital/financing activities. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is 3324 characters, which is consistent with an announcement rather than a full report.
2020-04-24 Chinese
关于公司控股股东减持股份计划的预披露公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding a planned reduction in shareholding by the company's controlling shareholder. It details the shareholder's current holdings, the planned reduction period, methods, and compliance with relevant securities regulations. There is no financial data, earnings information, or report attached or referenced as being published. The content fits the definition of a 'Major Shareholding Notification' as it informs about changes in significant share ownership levels. The document length is short and focused solely on the shareholding change plan, not a full report or financial statement.
2020-04-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.